Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Down 23.0% in December

Vivani Medical, Inc. (NASDAQ:VANI) saw a large drop in short interest in the month of December. As of December 31st, there was short interest totalling 358,000 shares, a drop of 23.0% from the December 15th total of 465,200 shares. Approximately 1.2% of the company’s stock are short sold. Based on an average daily trading volume, of 121,200 shares, the short-interest ratio is currently 3.0 days.

Vivani Medical Stock Up 0.4 %

Shares of VANI stock traded up $0.01 during trading hours on Thursday, reaching $1.21. 7,462 shares of the company’s stock were exchanged, compared to its average volume of 100,888. Vivani Medical has a fifty-two week low of $1.01 and a fifty-two week high of $7.80. The stock has a market capitalization of $71.38 million, a P/E ratio of -2.68 and a beta of 3.23. The business has a fifty day moving average price of $1.28 and a 200-day moving average price of $1.26.

Analyst Upgrades and Downgrades

Separately, HC Wainwright started coverage on Vivani Medical in a research report on Thursday, November 7th. They issued a “buy” rating and a $3.00 price target for the company.

Insider Buying and Selling at Vivani Medical

In other Vivani Medical news, Director Gregg Williams acquired 3,968,253 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average price of $1.26 per share, with a total value of $4,999,998.78. Following the completion of the transaction, the director now owns 4,695,861 shares in the company, valued at $5,916,784.86. The trade was a 545.38 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 44.30% of the company’s stock.

Institutional Trading of Vivani Medical

A hedge fund recently raised its stake in Vivani Medical stock. Geode Capital Management LLC increased its holdings in shares of Vivani Medical, Inc. (NASDAQ:VANI) by 4.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 342,891 shares of the company’s stock after acquiring an additional 15,008 shares during the period. Geode Capital Management LLC owned about 0.62% of Vivani Medical worth $401,000 at the end of the most recent reporting period. 6.78% of the stock is currently owned by hedge funds and other institutional investors.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.